Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jaguar Health, Inc. | Director | Convertible Promissory Note | 28.4K | $4.26B | $150,000.00 | Jun 24, 2025 | Indirect |
Jaguar Health, Inc. | Director | Warrant to Purchase Common Stock | 27K | Jun 24, 2025 | Indirect | ||
Jaguar Health, Inc. | Director | Stock option (right to buy) | 23.2K | Oct 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JAGX | Jaguar Health, Inc. | Jun 24, 2025 | 3 | $208M | 4 | Jun 26, 2025 | Director |
JAGX | Jaguar Health, Inc. | Mar 31, 2025 | 2 | $4.05B | 4 | Apr 2, 2025 | Director |
JAGX | Jaguar Health, Inc. | Oct 8, 2024 | 1 | $0 | 4 | Oct 10, 2024 | Director |
JAGX | Jaguar Health, Inc. | Aug 14, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Director |
JAGX | Jaguar Health, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
JAGX | Jaguar Health, Inc. | May 18, 2022 | 2 | $0 | 4 | May 18, 2022 | Director |
JAGX | Jaguar Health, Inc. | Mar 28, 2022 | 1 | $0 | 4 | Mar 30, 2022 | Director |
JAGX | Jaguar Health, Inc. | Jun 3, 2021 | 2 | -$775 | 4 | Jun 7, 2021 | Director |
JAGX | Jaguar Health, Inc. | May 18, 2021 | 2 | $0 | 4 | May 20, 2021 | Director |